These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32991074)

  • 1. Bisubstrate Ether-Linked Uridine-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.
    Makwana V; Ryan P; Malde AK; Anoopkumar-Dukie S; Rudrawar S
    ChemMedChem; 2021 Feb; 16(3):477-483. PubMed ID: 32991074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel bisubstrate uridine-peptide analogues bearing a pyrophosphate bioisostere as inhibitors of human O-GlcNAc transferase.
    Ryan P; Shi Y; von Itzstein M; Rudrawar S
    Bioorg Chem; 2021 May; 110():104738. PubMed ID: 33667901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thio-Linked UDP-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.
    Rafie K; Gorelik A; Trapannone R; Borodkin VS; van Aalten DMF
    Bioconjug Chem; 2018 Jun; 29(6):1834-1840. PubMed ID: 29723473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisubstrate UDP-peptide conjugates as human O-GlcNAc transferase inhibitors.
    Borodkin VS; Schimpl M; Gundogdu M; Rafie K; Dorfmueller HC; Robinson DA; van Aalten DM
    Biochem J; 2014 Feb; 457(3):497-502. PubMed ID: 24256146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-GlcNAc transferase inhibitors: current tools and future challenges.
    Trapannone R; Rafie K; van Aalten DM
    Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Versatile O-GlcNAc transferase assay for high-throughput identification of enzyme variants, substrates, and inhibitors.
    Kim EJ; Abramowitz LK; Bond MR; Love DC; Kang DW; Leucke HF; Kang DW; Ahn JS; Hanover JA
    Bioconjug Chem; 2014 Jun; 25(6):1025-30. PubMed ID: 24866374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate and product analogues as human O-GlcNAc transferase inhibitors.
    Dorfmueller HC; Borodkin VS; Blair DE; Pathak S; Navratilova I; van Aalten DM
    Amino Acids; 2011 Mar; 40(3):781-92. PubMed ID: 20640461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-GlcNAc Transferase: Structural Characteristics, Catalytic Mechanism and Small-Molecule Inhibitors.
    Ju Kim E
    Chembiochem; 2020 Nov; 21(21):3026-3035. PubMed ID: 32406185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New ELISA-based method for the detection of O-GlcNAc transferase activity in vitro.
    Qi J; Wang R; Zeng Y; Yu W; Gu Y
    Prep Biochem Biotechnol; 2017 Aug; 47(7):699-702. PubMed ID: 28296566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of O-GlcNAc transferase inhibitors.
    Gross BJ; Kraybill BC; Walker S
    J Am Chem Soc; 2005 Oct; 127(42):14588-9. PubMed ID: 16231908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced transfer of a photocross-linking N-acetylglucosamine (GlcNAc) analog by an O-GlcNAc transferase mutant with converted substrate specificity.
    Rodriguez AC; Yu SH; Li B; Zegzouti H; Kohler JJ
    J Biol Chem; 2015 Sep; 290(37):22638-48. PubMed ID: 26240142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small molecule that inhibits OGT activity in cells.
    Ortiz-Meoz RF; Jiang J; Lazarus MB; Orman M; Janetzko J; Fan C; Duveau DY; Tan ZW; Thomas CJ; Walker S
    ACS Chem Biol; 2015 Jun; 10(6):1392-7. PubMed ID: 25751766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The conserved threonine-rich region of the HCF-1
    Kapuria V; Röhrig UF; Waridel P; Lammers F; Borodkin VS; van Aalten DMF; Zoete V; Herr W
    J Biol Chem; 2018 Nov; 293(46):17754-17768. PubMed ID: 30224358
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological evaluation and molecular modeling of peptidomimetic compounds as inhibitors for O-GlcNAc transferase (OGT).
    Albuquerque SO; Barros TG; Dias LRS; Lima CHDS; Azevedo PHRA; Flores-Junior LAP; Dos Santos EG; Loponte HF; Pinheiro S; Dias WB; Muri EMF; Todeschini AR
    Eur J Pharm Sci; 2020 Nov; 154():105510. PubMed ID: 32801002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of human O-GlcNAc transferase and its complex with a peptide substrate.
    Lazarus MB; Nam Y; Jiang J; Sliz P; Walker S
    Nature; 2011 Jan; 469(7331):564-7. PubMed ID: 21240259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-GlcNAcase: Emerging Mechanism, Substrate Recognition and Small-Molecule Inhibitors.
    Elbatrawy AA; Kim EJ; Nam G
    ChemMedChem; 2020 Jul; 15(14):1244-1257. PubMed ID: 32496638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity Based High-Throughput Screening for Novel O-GlcNAc Transferase Substrates Using a Dynamic Peptide Microarray.
    Shi J; Sharif S; Ruijtenbeek R; Pieters RJ
    PLoS One; 2016; 11(3):e0151085. PubMed ID: 26960196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feedback Regulation of
    Lin CH; Liao CC; Chen MY; Chou TY
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK).
    Bullen JW; Balsbaugh JL; Chanda D; Shabanowitz J; Hunt DF; Neumann D; Hart GW
    J Biol Chem; 2014 Apr; 289(15):10592-10606. PubMed ID: 24563466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in
    Willems AP; Gundogdu M; Kempers MJE; Giltay JC; Pfundt R; Elferink M; Loza BF; Fuijkschot J; Ferenbach AT; van Gassen KLI; van Aalten DMF; Lefeber DJ
    J Biol Chem; 2017 Jul; 292(30):12621-12631. PubMed ID: 28584052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.